臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicationStatement med-sta-injection-example
status: Active
category: 門診
medication: 爽胰達注射劑100單位+50微克
subject: 陳加玲(official) Female, DoB: 1990-01-01 ( Medical record number (use: official, ))
effective: 2023-11-05 08:00:00+0800
dateAsserted: 2023-11-05 10:00:00+0800
reasonCode: 第一型糖尿病
note: 每日注射一次，於餐前一小時內注射，建議固定在同一餐的餐前注射
| Text | Timing | Route |
| 每日注射一次，於餐前一小時內注射 | Once per 1 days | 皮下注射 |